1105 related articles for article (PubMed ID: 25900794)
21. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
22. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
23. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN.
Wang ZX; Lu BB; Wang H; Cheng ZX; Yin YM
Arch Med Res; 2011 May; 42(4):281-90. PubMed ID: 21820606
[TBL] [Abstract][Full Text] [Related]
26. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
27. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
Ogretmen B; Safa AR
Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
[TBL] [Abstract][Full Text] [Related]
29. miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.
Wang M; Cai WR; Meng R; Chi JR; Li YR; Chen AX; Yu Y; Cao XC
Biochem Biophys Res Commun; 2018 Jun; 501(1):48-54. PubMed ID: 29678577
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
[TBL] [Abstract][Full Text] [Related]
31. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
[TBL] [Abstract][Full Text] [Related]
32. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
34. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.
Kim H; Choi H; Lee SK
Cancer Lett; 2015 Jan; 356(2 Pt B):733-42. PubMed ID: 25449437
[TBL] [Abstract][Full Text] [Related]
36. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo.
Yan LH; Wang XT; Yang J; Kong FB; Lian C; Wei WY; Luo W; Xie YB; Xiao Q
J Cell Biochem; 2014 Jan; 115(1):34-41. PubMed ID: 24038122
[TBL] [Abstract][Full Text] [Related]
37. [Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells].
Zhao ZL; Cai Y; Wang YY; Xia CL; Li CX; Chen SL; Yang QL; Chen CJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 44(4):400-9. PubMed ID: 26555418
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
[TBL] [Abstract][Full Text] [Related]
39. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.
Li B; Jin X; Meng H; Hu B; Zhang T; Yu J; Chen S; Guo X; Wang W; Jiang W; Wang J
Oncotarget; 2017 Jul; 8(29):47849-47860. PubMed ID: 28599307
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
